academic article

• The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo..  BMC cancer.  21:-. 2021
• R-ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis..  Molecular cancer therapeutics.  :-. 2015
• A novel pharmacologic activity of ketorolac for therapeutic benefit in ovarian cancer patients..  Clinical cancer research : an official journal of the American Association for Cancer Research.  :-. 2015
• Characterization of a Cdc42 GTPase Inhibitor and its Use as a Molecular Probe..  The Journal of biological chemistry.  :8531. 2013
• Characterization of a Cdc42 protein inhibitor and its use as a molecular probe. 2013